DAE HWA Pharmaceutical Dividends and Buybacks
Dividend criteria checks 0/6
DAE HWA Pharmaceutical is a dividend paying company with a current yield of 1.14%.
Key information
1.1%
Dividend yield
n/a
Buyback Yield
| Total Shareholder Yield | n/a |
| Future Dividend Yield | n/a |
| Dividend Growth | 0.7% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | ₩150.000 |
| Payout ratio | n/a |
Recent dividend and buyback updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: A067080 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: A067080 has only been paying a dividend for 5 years, and since then payments have not increased.
Dividend Yield vs Market
| DAE HWA Pharmaceutical Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (A067080) | 1.1% |
| Market Bottom 25% (KR) | 1.2% |
| Market Top 25% (KR) | 3.9% |
| Industry Average (Pharmaceuticals) | 1.1% |
| Analyst forecast (A067080) (up to 3 years) | n/a |
Notable Dividend: A067080's dividend (1.14%) isn’t notable compared to the bottom 25% of dividend payers in the KR market (1.23%).
High Dividend: A067080's dividend (1.14%) is low compared to the top 25% of dividend payers in the KR market (3.95%).
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate A067080's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Insufficient data to calculate A067080's cash payout ratio to determine if its dividend payments are covered by cash flows.